Dje, what kind of news you are expecting about PBT2?
IMO the possibilities are:
1. Cardiac Light Chain Amyloidosis ( Diomede et al, 2017 ) related activity (phase 2, perhaps orphan disease application)
2. Co-operation with Queensland university about treating antibiotic-resistant infections ( human and food industry )
3. Possible deal with the new big pharma co-operation to target development of new antibiotics
4. Covid-19 related news, PBT2 possibilities to kill viruses
5. patent-related news, related to the above issues
6. else
end of the downside- back in, page-91
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $789 | 225.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 13908266 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 130721053 | 31 |
View Market Depth
| Last trade - 14.19pm 08/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |